Blood test for ovarian germ cell tumors
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at tiny molecules in your blood (called microRNAs) to see if they can help doctors identify and manage malignant ovarian germ cell tumors. By giving a blood sample at diagnosis, you may help improve future detection and treatment for this rare cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be newly diagnosed with a type of ovarian cancer called a malignant ovarian germ cell tumor (starts in egg-making cells).
- You cannot have already started chemotherapy or had surgery for this tumor.
- You cannot be pregnant (this will be confirmed with a urine test if you're having surgery or chemo).
- You must be at least 16 years old (but the trial is mainly for adults).
- You must not have any other history of cancer.
- You must agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that looks for DNA changes to help detect ovarian cancer earlier. You would give a blood sample before your planned surgery or biopsy, and researchers will compare the test results with your pathology report to see how accurate it is.
This trial studies whether a simple blood test (liquid biopsy) can help tell if an ovarian mass is cancer or not, and if it can catch cancer early. If you're going to have surgery for a suspicious ovarian mass, this test might give extra information to guide your care.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study uses a simple blood test to look for tiny amounts of cancer DNA after you've finished your first treatment. It aims to see if this test can predict whether the cancer might come back, which could help guide future care.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
This study checks whether a special blood test (circulating tumor DNA) can help find ovarian cancer when it’s suspected. It may help doctors diagnose more accurately and sooner, so the right treatment can start sooner.
Hear when a new Germ Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.